Insider · CIK 0002040705
David DeLucia
cfoofficer
Files at KYNB (KYNTRA BIO, INC.). First filing -, latest -.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold
Signals
This insider’s open-market buys and sells, scored.
No scored open-market trades yet.
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 6, 2026 | KYNB KYNTRA BIO, INC. | FTax withholding Common Stock | -22 | $8.55 | $188 | 4,355 | 34 d ago |
| Mar 6, 2026 | KYNB KYNTRA BIO, INC. | FTax withholding Common Stock | -60 | $6.84 | $410 | 4,429 | Mar 10, 2026 |
| Feb 3, 2026 | KYNB KYNTRA BIO, INC. | AGrant or award Stock Option (Right to Buy)derivative | +26,000 | $0.00 | $0 | 26,000 | Feb 5, 2026 |
| Dec 6, 2025 | KYNB KYNTRA BIO, INC. | FTax withholding Common Stock | -52 | $8.42 | $438 | 4,489 | Dec 9, 2025 |
| Jun 6, 2025 | KYNB KYNTRA BIO, INC. | FTax withholding Common Stock | -51 | $7.83 | $399 | 4,594 | Sep 9, 2025 |
| Sep 6, 2025 | KYNB KYNTRA BIO, INC. | FTax withholding Common Stock | -53 | $12.10 | $641 | 4,541 | Sep 9, 2025 |
| Mar 6, 2025 | KYNB KYNTRA BIO, INC. | FTax withholding Common Stock | -2,325 | $0.39 | $907 | 116,137 | Mar 7, 2025 |
| Jan 9, 2025 | KYNB KYNTRA BIO, INC. | AGrant or award Stock Option (Right to Buy)derivative | +525,000 | $0.00 | $0 | 525,000 | Jan 10, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.